We are live on ! Find out more
EC

EcoR1 Capital Portfolio holdings

AUM $2.34B
1-Year Est. Return 204.53%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
+204.53%
3 Year Est. Return
+306.25%
5 Year Est. Return
+490.45%
10 Year Est. Return
+14,115.48%
AUM
$746M
AUM Growth
+$15.5M
Cap. Flow
-$23.2M
Cap. Flow %
-3.12%
Top 10 Hldgs %
84.69%
Holding
50
New
8
Increased
8
Reduced
3
Closed
21

Top Buys

1
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
+$28.5M
2
MGNX icon
MacroGenics
MGNX
+$21.3M
3
IMDZ
Immune Design Corp.
IMDZ
+$19.4M
4
ARRY
Array Biopharma Inc
ARRY
+$18.6M
5
APLS
Apellis Pharmaceuticals
APLS
+$16.8M

Top Sells

1
IMMU
Immunomedics Inc
IMMU
+$40M
2
MRNS
Marinus Pharmaceuticals, Inc
MRNS
+$21.3M
3
FBRX icon
Forte Biosciences
FBRX
+$18.7M
4
CTMX icon
CytomX Therapeutics
CTMX
+$15.1M
5
INDP icon
Indaptus Therapeutics
INDP
+$13.4M

Sector Composition

1 Healthcare 91.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADVM
26
DELISTED
Adverum Biotechnologies
ADVM
– –
-76,295
Closed -$2.79M
BMY icon
27
Bristol-Myers Squibb
BMY
$120B
– –
-17,060
Closed -$1.09M
CTMX icon
28
CytomX Therapeutics
CTMX
$790M
– –
-829,771
Closed -$15.1M
FATE icon
29
Fate Therapeutics
FATE
$350M
– –
-2,262,678
Closed -$8.96M
FBRX icon
30
Forte Biosciences
FBRX
$914M
– –
-4,006
Closed -$18.7M
INDP icon
31
Indaptus Therapeutics
INDP
$392M
– –
-670
Closed -$13.4M
INSM icon
32
Insmed
INSM
$23.7B
– –
-405,400
Closed -$12.7M
NTLA icon
33
Intellia Therapeutics
NTLA
$1.83B
– –
0
– –
OMER icon
34
Omeros
OMER
$758M
– –
-450,000
Closed -$9.73M
QURE icon
35
uniQure
QURE
$2.82B
– –
0
– –
RGLS
36
DELISTED
Regulus Therapeutics
RGLS
– –
-43,660
Closed -$6.55M
SGMO
37
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
– –
-222,388
Closed -$3.34M
TPST icon
38
Tempest Therapeutics
TPST
$16.6M
– –
-1,201
Closed -$4.99M
VRTX icon
39
Vertex Pharmaceuticals
VRTX
$121B
– –
0
– –
ZLAB icon
40
Zai Lab
ZLAB
$2.29B
– –
-159,535
Closed -$4.31M
SYRS
41
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
– –
-10,400
Closed -$1.53M
DCPH
42
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
– –
-45,000
Closed -$855K
MRNS
43
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
– –
-905,568
Closed -$21.3M
SGEN
44
DELISTED
Seagen Inc. Common Stock
SGEN
– –
-30,000
Closed -$1.63M
FSTX
45
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
– –
-4,000
Closed -$269K
CLVS
46
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-25,765
Closed -$2.12M
IMMU
47
DELISTED
Immunomedics Inc
IMMU
– –
-2,860,019
Closed -$40M
ONCE
48
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
0
– –
CASC
49
DELISTED
Cascadian Therapeutics, Inc.
CASC
– –
-3,000,000
Closed -$12.3M
CELG
50
DELISTED
Celgene Corp
CELG
– –
0
– –
1
2

Similar funds

G
GenTrust Miami, Florida $2.34B AUM 18.43% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return
BAM
Berkshire Asset Management Wilkes Barre, Pennsylvania $2.33B AUM 19.33% 1-Year Est. Return
CC
Capital Counsel New York $2.35B AUM 21.34% 1-Year Est. Return
HFM
Harvest Fund Management Beijing, China $2.35B AUM 49.85% 1-Year Est. Return
NO
Ninety One Cape Town, South Africa $2.33B AUM 92.42% 1-Year Est. Return
ST
Sageworth Trust Lancaster, Pennsylvania $2.33B AUM 20.04% 1-Year Est. Return
MFAM
Motley Fool Asset Management Alexandria, Virginia $2.33B AUM 21.93% 1-Year Est. Return